期刊文献+

重组肺癌抑癌基因1蛋白的表达、纯化及其多克隆抗体的制备

Expression and Purification of Recombinant Tumor Suppressor in Lung Cancer 1 Protein and Preparation of Its Polyclonal Antibody
原文传递
导出
摘要 目的表达、纯化重组人肺癌抑癌基因1(Tumorsuppressor in lung cancer1,TSLC1)蛋白,并制备其多克隆抗体。方法采用RT-PCR法扩增TSLC1基因全长编码区序列,克隆入原核表达质粒pQE30,转化大肠杆菌M15,IPTG诱导表达,表达的重组蛋白经Ni2+-NTA亲和层析纯化后,免疫家兔,ProteinA亲和层析纯化抗血清,并经Westernblot分析其反应原性。结果重组表达质粒pQE30-TSLC1经双酶切及测序鉴定证明构建正确。重组TSLC1蛋白的表达量约占菌体总蛋白的14%,主要以包涵体形式存在。纯化的重组蛋白纯度为93.4%,可与小鼠抗His-Tag单克隆抗体发生特异性反应。以其制备的多克隆抗体具有良好的抗原识别特异性。结论已成功制备TSLC1多克隆抗体,为深入研究TSLC1分子的生物学活性奠定了基础。 Objective To express and purify tumor suppressor in lung cancer 1(TSLC1)protein and prepare its polyclonal antibody.Methods The full-length sequence of encoding region of TSLC1 gene was amplified by RT-PCR and cloned into prokaryotic expression vector pQE30,and the constructed recombinant plasmid pQE30-TSLC1 was transformed to E.coli M15 for expression under induction of IPTG.The expressed protein was purified by Ni2+-NTA affinity chromatography and used for the immunization of rabbits.The antisera were purified by Protein A affinity chromatography and analyzed for reactogenicity by Western blot.Results Both restriction analysis and sequencing proved that recombinant plasmid pQE30-TSLC1 was constructed correctly.Recombinant TSLC1 protein mainly existed in a form of inclusion body and contained about 14% of total somatic protein.Purified TSLC1 protein reached a purity of 93.4% and showed specific reaction with mouse anti-His-Tag monoclonal antibody.The polyclonal antibody prepared with purifed TSLC1 protein showed high specificity in antigen recognition.Conclusions The polyclonal antibody against TSLC1 was successfully prepared,which laid a foundation of further study on the biological activity of TSLC1 molecules.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第12期1329-1332,共4页 Chinese Journal of Biologicals
关键词 肺癌抑癌基因1 原核细胞 基因表达 纯化 抗体 Tumor suppressor in lung cancer 1(TSLC1) Prokaryotic cells Gene expression Purification Antibody
  • 相关文献

参考文献6

  • 1Murakami Y. Involvement of a cell adbesion molecule. TSLCI / IGSF4, in human oncngenesis [J ]. Cancer Sci, 2005, 96 (9) : 543-552.
  • 2Heller G, Fong KM, Girard L, et al. Expression and methylation pattern of TSI,C1 cascade genes in lung carcinomas [J]. Oncogene, 2006, 25 (6):959-968.
  • 3Ito T, Shimada Y, Hashimoto Y, et al. Involvement of TSLC1- in progression of esophageal squamous cell carcinoma [J]. Cancer Res. 2003. 63 ( 19 ) : 6320-6326.
  • 4Yang YX, Yang AH, Yang ZJ, et al. Involvement of tumor suppressor in lung cancer I gene expression in cervical carcinogenesis [ J ]. Int J Gynecol Cancer, 2006, 16 ( 5 ) : 1868-1872.
  • 5Heller G, Geradts J, Ziegler B, et al. Downregulation of TSLCI and DAL-1 expression oecurs frequently in breast cancer [J]. Breast Cancer Res Treat, 2007, 103 (3):283-291.
  • 6Fu L, Gao Z, Zhang X, et al. Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADMI. and its interacting partner DAL-1 in nasal NK/T-cell lymphoma [ J ]. Int J Cancer, 2009, 124 ( 7 ) : 1572-1578.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部